News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • India will continue bilateral trade talks with the U.S. after Washington imposed a 10% tariff on about 55% of Indian exports.
  • Brazil refused visas for two U.S. officials, raising bilateral tensions ahead of Brazil's October presidential election.
  • Analysts pitch tactical buy trades across sectors: fintech (SoFi), gaming (Take-Two), semiconductors (AMD), aviation (Joby), and small caps.
  • AMD is positioned to benefit from rising AI infrastructure demand, prompting a bullish trade setup despite rich valuation.
  • Broadcasters like Gray Media are being bought ahead of expected political-ad spending into the 2026 cycle.
  • Royalty names (Gold Royalty, Kimbell) are recommended for improving cash flow and potential re-rating as production and acquisitions accelerate.

Latest Articles

Insulet Shares Slide After Voluntary Recall of Millions of Omnipod Pods

Insulet Shares Slide After Voluntary Recall of Millions of Omnipod Pods

Insulet reported a voluntary Medical Device Correction covering specific lots of Omnipod Pods after discovering a manufacturing defect that can lead to insulin under-delivery. Roughly 7 million Pods are included, stock fell about 6% in after-hours trading, and the company says it has identified the cause and can supply replacements at no cost.

Cricut CEO Ashish Arora Sells Shares Following Pre-Planned Transaction

Cricut CEO Ashish Arora Sells Shares Following Pre-Planned Transaction

Ashish Arora, the Chief Executive Officer and Director of Cricut, Inc. (NASDAQ:CRCT), executed a significant sale of company stock totaling $238,710 on May 22, 2026. This transaction involved 60,000 shares of Class A Common Stock. The sales were conducted under the framework of a Rule 10b5-1 trading plan, which Arora had established previously on A…

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody

Jade Biosciences has dosed the first participant in its first-in-human Phase 1 trial evaluating JADE201, an investigational half-life extended and afucosylated monoclonal antibody targeting BAFF-R to deplete B cells in autoimmune diseases. Interim data expected in 2027 will guide indication prioritization, particularly in rheumatoid arthritis, with…

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer, Inc. showcases its Proteograph Product Suite and AI-driven multi-cancer screening technology at the 2026 ASMS Annual Conference, highlighting breakthroughs in scalable proteomics and data processing infrastructure. Collaborations include large-scale plasma proteomics studies for precision medicine and advancements in biomarker discovery, unde…

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

Myriad Genetics has launched Prolaris + AI, a novel prostate cancer diagnostic test that integrates molecular biomarker data with AI-driven digital pathology to better assess prostate cancer aggressiveness and personalize active surveillance plans. This innovative test enhances prognostic accuracy by combining traditional molecular scoring with an …

Ming Shing Group Holdings Limited Announces Entering into Stock Purchase Agreement, Note Purchase Agreement and Convertible Promissory Notes

Ming Shing Group Holdings Limited Announces Entering into Stock Purchase Agreement, Note Purchase Agreement and Convertible Promissory Notes

Ming Shing Group Holdings Limited announced entering into a stock purchase agreement to acquire PMA Nano Carbon Tech Limited for $110 million through issuing convertible promissory notes. This acquisition aims to expand Ming Shing's portfolio into graphene-based thermal management technologies with applications across AI hardware cooling, new energ…

Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Assembly Biosciences has completed a registered public offering of approximately 3.9 million common shares and 415,000 pre-funded warrants, raising gross proceeds of $115 million. The company plans to use the funds to advance clinical development of its therapeutic candidates targeting serious viral and liver diseases and for general corporate purp…

Zscaler Announces Strong Third-Quarter Fiscal 2026 Results

Zscaler Announces Strong Third-Quarter Fiscal 2026 Results

Zscaler Inc. announced its Q3 fiscal 2026 results with revenue and ARR growth of 25% YoY, record profitability with non-GAAP operating margin at 23%, and strong cash flow performance. The company highlighted strategic moves targeting AI-driven cybersecurity enhancements, including acquisitions and partnerships. Guidance for fiscal 2026 was raised, …